Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0166
-0.0014 (-7.78%)
At close: Oct 16, 2026
Oncotelic Therapeutics Employees
As of December 31, 2025, Oncotelic Therapeutics had 43 total employees, including 38 full-time and 5 part-time employees. The number of employees increased by 13 or 43.33% compared to the previous year. That makes Oncotelic Therapeutics the 35,639th largest employer in the world and 4,824th in the United States.
Employees
43
Change (1Y)
13
Growth (1Y)
43.33%
Revenue / Employee
$6,098
Profits / Employee
$6,036,465
Market Cap
7.59M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 43 | 13 | 43.33% | 38 | 5 |
| Dec 31, 2024 | 30 | 8 | 36.36% | 26 | 4 |
| Dec 31, 2023 | 22 | 0 | - | 22 | 0 |
| Dec 31, 2022 | 22 | 6 | 37.50% | 22 | 0 |
| Dec 31, 2021 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| OSR Health | 22 |
| Zeo ScientifiX | 20 |
| Brainstorm Cell Therapeutics | 19 |
| Reviva Pharmaceuticals Holdings | 14 |
| Hepion Pharmaceuticals | 2 |
Oncotelic Therapeutics News
- 14 days ago - PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026 - GlobeNewsWire
- 2 months ago - Oncotelic Therapeutics, Inc. to Present at the OTCQB Virtual Investor Conference on August 6th - GlobeNewsWire
- 2 months ago - Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus) - GlobeNewsWire
- 3 months ago - Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway - GlobeNewsWire
- 3 months ago - Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003 - GlobeNewsWire
- 4 months ago - Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026 - GlobeNewsWire
- 4 months ago - Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services - GlobeNewsWire
- 4 months ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Exploration of Nanoparticle, Targeted Drug-Delivery Technologies - GlobeNewsWire